The cost of laparoscopic oophorectomy (ovary removal surgery) in Spain is approximately $11,400. This price is for a bilateral salpingo-oophorectomy, which involves the removal of both ovaries and fallopian tubes. The procedure includes the surgeon"s fees, anesthesia, and operating room charges.
| Turkey | Austria | Spain | |
| Laparoscopic oophorectomy (ovary removal surgery) | from $5,100 | ≈ $4,200 | from $15,700 |
Dr. Fernandez Oliva specializes in laparoscopic and robotic gynecological surgery, trained at Hospital Vall d'Hebrón in Barcelona.
Dr. Jordi Antoni Vives is a specialist in gynecology and obstetrics at Teknogin (Centro Médico Teknon, Barcelona). He focuses on gynecologic oncology surgery, complex uterine and pelvic pathology, and tumor board coordination. He has led Obstetrics at Hospital CIMA since 2015. He has been a consultant physician at Parc Taulí since 1990.
Education/accreditations: Degree in Medicine and Surgery, University of Barcelona (1983). MIR residency in Gynecology and Obstetrics (1990). European University Diploma in Operative Endoscopy in Gynecology, advanced level (2000). Da Vinci robotic surgery accreditation (2010). Training stays at Mayo Clinic, Scottsdale (1994 and 1999).
Leadership/memberships/awards: Coordinator and president of the Functional Unit of Gynecologic Oncology and the Tumor Committee at Parc Taulí. Member of the Spanish, Catalan, and European Societies of Gynecology and Obstetrics, and of the GEICO Cervical Cancer Committee. President of the collegiate section of Gynecology and Obstetrics at the Official College of Physicians of Barcelona. Professional Excellence Award (2015) and Top Doctors Awards 2016.
Dr. Xavier Centeno Fornies trained internationally at prestigious institutions like the Mayo Clinic for advanced laparoscopic techniques. He has been leading the surgery department at Centro Médico Teknon since 1993.
Dr. Javier Cortés Castán, MD, PhD, is a medical oncologist. He is the Director and Founder of the International Breast Cancer Center (IBCC) at Centro Médico Teknon (Quironsalud) in Barcelona. He has 25+ years of practice. He specializes in HER2‑positive and triple‑negative breast cancer. Expertscape ranks him #1 worldwide in HER2+.
He has authored 550+ publications and given 800+ presentations. He leads 150+ active clinical trials. His work helped enable 12 metastatic breast cancer treatments approved in Europe. He was a key leader in KEYNOTE‑522, KEYNOTE‑355, and DESTINY‑Breast03. He is the only Spanish oncologist with two papers in CA: A Cancer Journal for Clinicians. He is a 2026 Giants of Cancer Care honoree. IBCC provides advanced care and access to trials. Centro Médico Teknon is JCI‑accredited.